2024 Inova Fairfax MGR (Enduring Material): Recent Updates in Myositis

Topic: Recent Updates in Myositis

Learning Objectives

  • Advance education in basic scientific principles applicable to clinical situations.
  • Disseminate information regarding disease prevention and public health.
  • Improve understanding of psychosocial and legal issues as they apply to delivery of excellent patient care.
  • Provide updates in medical diagnosis and treatment to improve patient outcome.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
Course opens: 
08/20/2024
Course expires: 
08/19/2025
Cost:
$0.00
Part of: 
2024 Inova Fairfax Medicine Grand Rounds (Enduring Material)
Rating: 
0
Speaker(s)

Rohit Aggarwal, MD, MS

has a financial relationship (Grant Or Contract) with Mallinckrodt;.
has a financial relationship (Consulting Fee) with Nuvig Therapeutics;.
has a financial relationship (Consulting Fee) with Alexion;.
has a financial relationship (Grant Or Contract) with Q32;.
has a financial relationship (Consulting Fee) with AstraZeneca;.
has a financial relationship (Grant Or Contract) with Bristol Myers-Squibb;.
has a financial relationship (Consulting Fee) with Corbus;.
has a financial relationship (Consulting Fee) with Galapagos;.
has a financial relationship (Consulting Fee) with Janssen;.
has a financial relationship (Consulting Fee) with Novartis;.
has a financial relationship (Consulting Fee) with Pfizer;.
has a financial relationship (Consulting Fee) with Artasome;.
has a financial relationship (Consulting Fee) with Teva;.
has a financial relationship (Consulting Fee) with Bristol Myers-Squibb;.
has a financial relationship (Consulting Fee) with Capstanx;.
has a financial relationship (Grant Or Contract) with EMD Serono;.
has a financial relationship (Consulting Fee) with Immunovant;.
has a financial relationship (Consulting Fee) with Kyverna;.
has a financial relationship (Consulting Fee) with Merck;.
has a financial relationship (Grant Or Contract) with Pfizer;.
has a financial relationship (Consulting Fee) with Argenx;.
has a financial relationship (Consulting Fee) with Sanofi;.
has a financial relationship (Grant Or Contract) with Boehringer Ingelheim;.
has a financial relationship (Consulting Fee) with Capella Bioscience;.
has a financial relationship (Consulting Fee) with EMD Serono;.
has a financial relationship (Consulting Fee) with I-Cell;.
has a financial relationship (Consulting Fee) with Kezar;.
has a financial relationship (Consulting Fee) with Manta Medicines Corporation;.
has a financial relationship (Consulting Fee) with Octapharma;.
has a financial relationship (Consulting Fee) with ANI Pharmaceuticals;.
has a financial relationship (Consulting Fee) with Roivant;.
has a financial relationship (Consulting Fee) with Boehringer Ingelheim;.
has a financial relationship (Consulting Fee) with Cabaletta Bio;.
has a financial relationship (Consulting Fee) with CSL Behring;.
has a financial relationship (Consulting Fee) with Horizon Therapeutics;.
has a financial relationship (Grant Or Contract) with Janssen;.

Accreditation Statement

The Medical Society of Virginia is a member of the Southern States CME Collaborative, an ACCME Recognized Accreditor. Inova Health System Office of Continuing Medical Education is accredited by the Southern States CME Collaborative to provide continuing medical education for physicians.

Credit Designation Statement

The Inova Office of Continuing Medical Education designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physicians may claim up to 1.0 credits in Type 1 CME on the Virginia Board of Medicine Continued Competency an

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

Price

Cost:
$0.00
Please login or register to take this course.